An antigen is a pathogen or any other substance that that can cause a given infection. They are foreign invaders such as bacteria and viruses. Rapid Covid-19 antigen tests look for antigen proteins that are usually present on the viral surface. For coronavirus, the proteins are usually from the surface spikes from the virus structure. The antigens can be detected even before the onset of the signs and symptoms of Covid-19. Similar to the rapid Covid-19 PCR test, the rapid Covid-19 antigen test is a diagnostic test for people who currently have Covid-19.
Rapid Covid-19 antigen test provides an overall COVID-19 testing dimension with an advantage in connecting with shorter turnaround times in addition to low cost, especially in circumstances where RT-PCR testing amplitude is limited. Rapid antigen testing brings out the best performance in situations where the viral load is high. It is also an efficient method in the early phases of the illness when the actual diagnosis cannot be made because the symptoms have not yet emerged. Additionally, it is also effective during the initial symptomatic cases until the 5th day from the period of symptom outbreak. In high prevalence settings, the utilization of rapid antigen tests is suitable for detecting true infection. In low prevalence settings, it is suitable to point out highly infectious instances quickly. Rapid antigen tests can help minimize further transmission via early identification of extremely contagious cases, allowing a quick implementation of contact tracing.
The use of rapid antigen test by the European Commission Recommendation was published on October 28th 2020, on COVID-19 testing strategies. This recommendation required the European Union and the United Kingdom to agree on the criteria that would be applicable for choosing rapid antigen tests and debate on the information about the outcome of validation studies. This ECDC document aimed to enable more discussions allying Member states to reach an agreement on which method to be used for the determination of rapid antigen test, including scheme and settings suitable for using rapid antigen tests. ECDC accords with the minimal performance prerequisite placed by WHO at greater or equal to 80% sensitivity and greater than or equal to 79% precision. The FDA also recently issued an Emergency Use Authorization (EUA) for rapid Covid-19 antigen test. This is an effort to obtain a quick and effective method of diagnosing coronavirus.
Rapid Covid-19 antigen tests provide multiple functional benefits as compared to RT-PCR tests for the identification of SARS-CoV-2 and can be used to scale up testing to greater levels. Lots of tests can be performed in a single day using the antigen test. Rapid antigen test are available for both laboratory-based tests and at-home patient kits. In addition, the results are obtained within 10-30 minutes after the start of the analysis.
For this test, samples are collected through a swab of the anterior nares, nasopharyngeal swab, or saliva. The sample is then placed in a paper strip having artificial antibodies, which are made to combine with coronavirus antigens. The antigens bind to the strips, and a visual readout is given. The process does not require expensive equipment or any special training.
With the rise in coronavirus cases, accurate and reliable testing kits are a necessity around the world. Finding reliable Covid-19 testing products is now easier. You can obtain various rapid Covid-19 test kits at affordable prices from Rapid Connect Medical. Our kits are designed carefully with accuracy and simplicity in mind. Our Rapid Covid-19 antigen test kits are designed with the following features:
- High specificity of 100%
- Highly sensitive – above 98%
- The kit provides high accuracy, sensitivity, and specificity.
- Simple to use, with systematic instructions.
- Quick and well-grounded results in 10 minutes or less
- Can be kept and used at room temperature
- All test constituents – inclusive of aseptic swabs are included.
- There are no crossways with human pathogenic coronaviruses.
We supply both large and small quantities of test kits. Our rapid Covid-19 antigen test kits have high sensitivity and specificity.
Rapid COVID-19 antigen tests are used for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in individuals suspected of coronavirus. During the acute phase of the infection, positive results indicate the presence of viral antigens. Positive results obtained from rapid COVID-19 antigen kits are usually highly accurate. The tests can be very specific but not as sensitive as molecular tests.
When the COVID-19 antigen test results are negative, you will need the patient’s history, clinical observations, or epidemiological information to confirm this type of status. Since negative results are presumptive, so a confirmation test through molecular assay is crucial. If the patient shows symptoms of COVID-19 but the antigen test shows a negative result, then a molecular test is required. This antigen test will show an active infection of COVID-19. This kit can detect the live virus in the first few days of infection. This kit is FDA EUA Authorized and also has a CLIA waiver.
You need to be proficient in performing COVID-19 tests in point of care settings for you to use a POC rapid antigen test. We are talking about medical professionals, clinical laboratory personnel, and trained operators. Individuals who think that they have coronavirus disease 2019 (COVID-19) and need to get a test to verify are advised to contact their health care providers as soon as possible.
If you are looking to make large orders of Rapid COVID-19 antigen test kits online, approved by the FDA under EUA, then you can do that right now from Rapid Connect Medical. We can supply quantities as large as 10,000,000 kits or more. Please contact our sales team for more information on how to make large and cost-effective orders from Rapid Connect Medical.
We have access to reliable test kits that can be sent to countries around the world. Our test kits are high in sensitivity and specificity. All of our products carry the FDA EUA Authorization and are backed by the research of the CDC, WHO, and university scientific studies. Our products are based on findings and guidance that helps protect the public and help the person using it know their status of infection or not.
By knowing the probability of spreading the virus and knowing infectious diagnostics can help end the global spread of Covid-19. By helping identify infected individuals, the proper response can be initiated and performed by medical professionals. These antigen tests are easy to administer with a nasal or throat saliva sample from the persons being tested. False positive report rates are confirmed low.
his test also is easy to collect samples and doesn’t require testing tools or complex certified lab facilities to diagnose the outcomes. You can help keep outbreaks in your organizations, school or country to a minimum. We offer fast shipping methods for our antibody test kits at an affordable rate. You can order test kits online at https://rapidconnectmedical.com/
Be sure to follow us on Facebook, LinkedIn, YouTube, and Twitter for updates, news, and new product announcements. We will also be having press events in the near future so keep an eye out for more news about Rapid Connect Medical!
Stop the Spread – Test Yourself Now